Serum Institute of India to apply for Oxford vaccine trials in India in a week
The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine.Commenting on the AstraZeneca-Oxford vaccine's results, Adar Poonawalla, CEO, Serum Institute of…